| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure
|
Razeghian-Jahromi, Iman
|
|
|
26 |
2 |
p. 371-380
|
article
|
| 2 |
A reappraisal of the pharmacologic management of gastrointestinal bleeding in patients with continuous flow left ventricular assist devices
|
Littlefield, Audrey J.
|
|
|
26 |
2 |
p. 277-288
|
article
|
| 3 |
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
|
Sabbah, Hani N.
|
|
|
26 |
2 |
p. 237-253
|
article
|
| 4 |
Beyond genomics—technological advances improving the molecular characterization and precision treatment of heart failure
|
Lavine, Kory J.
|
|
|
26 |
2 |
p. 405-415
|
article
|
| 5 |
Cardiac complications in inherited mitochondrial diseases
|
Behjati, Mohaddeseh
|
|
|
26 |
2 |
p. 391-403
|
article
|
| 6 |
Cardiac contractility modulation for patient with refractory heart failure: an updated evidence-based review
|
Cappannoli, Luigi
|
|
|
26 |
2 |
p. 227-235
|
article
|
| 7 |
Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction
|
Patel, Peysh A.
|
|
|
26 |
2 |
p. 217-226
|
article
|
| 8 |
Cardiorespiratory fitness in patients with type 2 diabetes: A missing piece of the puzzle
|
Tadic, Marijana
|
|
|
26 |
2 |
p. 301-308
|
article
|
| 9 |
Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings
|
Mandoli, Giulia Elena
|
|
|
26 |
2 |
p. 263-275
|
article
|
| 10 |
Correction to: Vitamin c: historical perspectives and heart failure
|
Malik, Akshi
|
|
|
26 |
2 |
p. 451
|
article
|
| 11 |
Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample
|
Mekhaimar, Menatalla
|
|
|
26 |
2 |
p. 289-300
|
article
|
| 12 |
Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection
|
Rankovic, Marina
|
|
|
26 |
2 |
p. 437-450
|
article
|
| 13 |
Drug development in oncology and devices—lessons for heart failure drug development and approval? a review
|
Davison, Beth A.
|
|
|
26 |
2 |
p. 255-262
|
article
|
| 14 |
Heal the heart through gut (hormone) ghrelin: a potential player to combat heart failure
|
Gupta, Shreyasi
|
|
|
26 |
2 |
p. 417-435
|
article
|
| 15 |
Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure
|
Elzeneini, Mohammed
|
|
|
26 |
2 |
p. 355-361
|
article
|
| 16 |
Hospitalizations in adult patients with congenital heart disease: an emerging challenge
|
Ntiloudi, Despoina
|
|
|
26 |
2 |
p. 347-353
|
article
|
| 17 |
Mechanisms of COVID-19-induced heart failure: a short review
|
Adeghate, Ernest A.
|
|
|
26 |
2 |
p. 363-369
|
article
|
| 18 |
Non-invasive cardiac allograft rejection surveillance: reliability and clinical value for prevention of heart failure
|
Dandel, Michael
|
|
|
26 |
2 |
p. 319-336
|
article
|
| 19 |
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
|
Margonato, Davide
|
|
|
26 |
2 |
p. 337-345
|
article
|
| 20 |
Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications
|
Triposkiadis, Filippos
|
|
|
26 |
2 |
p. 381-389
|
article
|
| 21 |
Takotsubo cardiomyopathy with low ventricular ejection fraction and apical ballooning predicts mortality: a systematic review and meta-analysis
|
Chiang, Lorraine Lok-Wing
|
|
|
26 |
2 |
p. 309-318
|
article
|
Journal description